Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Vaag

Showing results (51-60 of 235) with videos related to

Pageof 24
Sort By:
The Cochrane Database of Systematic Reviews|June 17, 2011
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusBianca Hemmingsen, Søren S Lund, Christian Gluud, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2009
Age-dependent nongenetic influences of birth weight and adult body fat on insulin sensitivity in twinsRikke Nygaard Monrad, Louise Groth Grunnet, Eva Lind Rasmussen, et al.
International Journal of Obesity (2005)|July 8, 2026
Characterization of white adipocyte heterogeneity using data-driven microscopyJieyu Zhang, Christian Simonsson, Ayesha Fawad, et al.
Diabetologia|January 25, 2018
Telomere length is reduced in 9- to 16-year-old girls exposed to gestational diabetes in uteroLine Hjort, Regan Vryer, Louise G Grunnet, et al.
Plos One|November 18, 2008
Altered PI3-kinase/Akt signalling in skeletal muscle of young men with low birth weightChristine B Jensen, Malgorzata S Martin-Gronert, Heidi Storgaard, et al.
The Cochrane Database of Systematic Reviews|November 12, 2013
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusBianca Hemmingsen, Søren S Lund, Christian Gluud, et al.
Diabetes Care|June 23, 2009
Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetesClaus M Larsen, Mirjam Faulenbach, Allan Vaag, et al.
Diabetes Research and Clinical Practice|October 5, 2010
Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysisKarin D Hove, Kristine Færch, Thóra B Bödvarsdóttir, et al.
BMJ (Clinical Research Ed.)|April 21, 2012
Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analysesBianca Hemmingsen, Louise Lundby Christensen, Jørn Wetterslev, et al.
Diabetes Care|May 24, 2022
Novel Subgroups of Type 2 Diabetes Display Different Epigenetic Patterns That Associate With Future Diabetic ComplicationsSilja Schrader, Alexander Perfilyev, Emma Ahlqvist, et al.
Pageof 24

Showing results (51-60 of 235) with videos related to

Sort By:
Pageof 24
The Cochrane Database of Systematic Reviews|June 17, 2011
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusBianca Hemmingsen, Søren S Lund, Christian Gluud, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2009
Age-dependent nongenetic influences of birth weight and adult body fat on insulin sensitivity in twinsRikke Nygaard Monrad, Louise Groth Grunnet, Eva Lind Rasmussen, et al.
International Journal of Obesity (2005)|July 8, 2026
Characterization of white adipocyte heterogeneity using data-driven microscopyJieyu Zhang, Christian Simonsson, Ayesha Fawad, et al.
Diabetologia|January 25, 2018
Telomere length is reduced in 9- to 16-year-old girls exposed to gestational diabetes in uteroLine Hjort, Regan Vryer, Louise G Grunnet, et al.
Plos One|November 18, 2008
Altered PI3-kinase/Akt signalling in skeletal muscle of young men with low birth weightChristine B Jensen, Malgorzata S Martin-Gronert, Heidi Storgaard, et al.
The Cochrane Database of Systematic Reviews|November 12, 2013
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusBianca Hemmingsen, Søren S Lund, Christian Gluud, et al.
Diabetes Care|June 23, 2009
Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetesClaus M Larsen, Mirjam Faulenbach, Allan Vaag, et al.
Diabetes Research and Clinical Practice|October 5, 2010
Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysisKarin D Hove, Kristine Færch, Thóra B Bödvarsdóttir, et al.
BMJ (Clinical Research Ed.)|April 21, 2012
Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analysesBianca Hemmingsen, Louise Lundby Christensen, Jørn Wetterslev, et al.
Diabetes Care|May 24, 2022
Novel Subgroups of Type 2 Diabetes Display Different Epigenetic Patterns That Associate With Future Diabetic ComplicationsSilja Schrader, Alexander Perfilyev, Emma Ahlqvist, et al.
Pageof 24